| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | importin-alpha family protein binding | 1.56e-08 | 21 | 27 | 4 | GO:0061676 | |
| GeneOntologyMolecularFunction | syntaxin binding | 5.46e-06 | 87 | 27 | 4 | GO:0019905 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | GOLGA6C GOLGA6D DLG4 GOLGA6B GOLGA6A LIMCH1 AFAP1 SYNE2 SORBS3 | 8.53e-06 | 1099 | 27 | 9 | GO:0008092 |
| GeneOntologyMolecularFunction | SNARE binding | 3.20e-05 | 136 | 27 | 4 | GO:0000149 | |
| GeneOntologyMolecularFunction | microtubule binding | 7.36e-04 | 308 | 27 | 4 | GO:0008017 | |
| GeneOntologyMolecularFunction | DNA secondary structure binding | 1.40e-03 | 41 | 27 | 2 | GO:0000217 | |
| GeneOntologyMolecularFunction | tubulin binding | 2.47e-03 | 428 | 27 | 4 | GO:0015631 | |
| GeneOntologyBiologicalProcess | Golgi disassembly | 6.00e-09 | 18 | 26 | 4 | GO:0090166 | |
| GeneOntologyBiologicalProcess | positive regulation of protein glycosylation | 7.59e-09 | 19 | 26 | 4 | GO:0060050 | |
| GeneOntologyBiologicalProcess | Golgi ribbon formation | 1.73e-08 | 23 | 26 | 4 | GO:0090161 | |
| GeneOntologyBiologicalProcess | regulation of protein glycosylation | 2.07e-08 | 24 | 26 | 4 | GO:0060049 | |
| GeneOntologyBiologicalProcess | mitotic spindle organization | 2.84e-08 | 151 | 26 | 6 | GO:0007052 | |
| GeneOntologyBiologicalProcess | Golgi localization | 3.41e-08 | 27 | 26 | 4 | GO:0051645 | |
| GeneOntologyBiologicalProcess | meiotic spindle assembly | 3.98e-08 | 28 | 26 | 4 | GO:0090306 | |
| GeneOntologyBiologicalProcess | organelle inheritance | 3.98e-08 | 28 | 26 | 4 | GO:0048308 | |
| GeneOntologyBiologicalProcess | Golgi inheritance | 3.98e-08 | 28 | 26 | 4 | GO:0048313 | |
| GeneOntologyBiologicalProcess | asymmetric cell division | 8.96e-08 | 34 | 26 | 4 | GO:0008356 | |
| GeneOntologyBiologicalProcess | mitotic spindle assembly | 9.66e-08 | 92 | 26 | 5 | GO:0090307 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization involved in mitosis | 1.01e-07 | 187 | 26 | 6 | GO:1902850 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein biosynthetic process | 1.14e-07 | 36 | 26 | 4 | GO:0010560 | |
| GeneOntologyBiologicalProcess | meiotic spindle organization | 1.27e-07 | 37 | 26 | 4 | GO:0000212 | |
| GeneOntologyBiologicalProcess | positive regulation of glycoprotein metabolic process | 1.76e-07 | 40 | 26 | 4 | GO:1903020 | |
| GeneOntologyBiologicalProcess | spindle organization | 2.95e-07 | 224 | 26 | 6 | GO:0007051 | |
| GeneOntologyBiologicalProcess | microtubule nucleation | 7.49e-07 | 57 | 26 | 4 | GO:0007020 | |
| GeneOntologyBiologicalProcess | spindle assembly | 1.22e-06 | 153 | 26 | 5 | GO:0051225 | |
| GeneOntologyBiologicalProcess | regulation of glycoprotein biosynthetic process | 1.62e-06 | 69 | 26 | 4 | GO:0010559 | |
| GeneOntologyBiologicalProcess | centrosome cycle | 1.72e-06 | 164 | 26 | 5 | GO:0007098 | |
| GeneOntologyBiologicalProcess | protein homotetramerization | 2.52e-06 | 77 | 26 | 4 | GO:0051289 | |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | 2.64e-06 | 179 | 26 | 5 | GO:0031023 | |
| GeneOntologyBiologicalProcess | regulation of glycoprotein metabolic process | 2.94e-06 | 80 | 26 | 4 | GO:1903018 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 6.04e-06 | 212 | 26 | 5 | GO:0000070 | |
| GeneOntologyBiologicalProcess | negative regulation of protein binding | 9.03e-06 | 106 | 26 | 4 | GO:0032091 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 1.10e-05 | 240 | 26 | 5 | GO:0140013 | |
| GeneOntologyBiologicalProcess | negative regulation of autophagy | 1.12e-05 | 112 | 26 | 4 | GO:0010507 | |
| GeneOntologyBiologicalProcess | protein tetramerization | 1.16e-05 | 113 | 26 | 4 | GO:0051262 | |
| GeneOntologyBiologicalProcess | positive regulation of axonogenesis | 1.20e-05 | 114 | 26 | 4 | GO:0050772 | |
| GeneOntologyBiologicalProcess | microtubule polymerization | 1.33e-05 | 117 | 26 | 4 | GO:0046785 | |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 1.45e-05 | 254 | 26 | 5 | GO:0000819 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | 1.54e-05 | 957 | 26 | 8 | GO:0097435 | |
| GeneOntologyBiologicalProcess | meiotic chromosome segregation | 1.57e-05 | 122 | 26 | 4 | GO:0045132 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 1.88e-05 | 268 | 26 | 5 | GO:1903046 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | 2.26e-05 | 720 | 26 | 7 | GO:0000226 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle | 2.35e-05 | 1014 | 26 | 8 | GO:0000278 | |
| GeneOntologyBiologicalProcess | nuclear division | 3.43e-05 | 512 | 26 | 6 | GO:0000280 | |
| GeneOntologyBiologicalProcess | cell cycle process | GOLGA6C GOLGA6D GOLGA6B GOLGA6A CLSPN RECQL4 MYBL1 SPICE1 PCNT | 4.06e-05 | 1441 | 26 | 9 | GO:0022402 |
| GeneOntologyBiologicalProcess | mitotic nuclear division | 4.13e-05 | 316 | 26 | 5 | GO:0140014 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum to Golgi vesicle-mediated transport | 4.45e-05 | 159 | 26 | 4 | GO:0006888 | |
| GeneOntologyBiologicalProcess | organelle assembly | 5.36e-05 | 1138 | 26 | 8 | GO:0070925 | |
| GeneOntologyBiologicalProcess | microtubule polymerization or depolymerization | 5.52e-05 | 168 | 26 | 4 | GO:0031109 | |
| GeneOntologyBiologicalProcess | Golgi organization | 5.52e-05 | 168 | 26 | 4 | GO:0007030 | |
| GeneOntologyBiologicalProcess | negative regulation of binding | 5.78e-05 | 170 | 26 | 4 | GO:0051100 | |
| GeneOntologyBiologicalProcess | organelle fission | 6.29e-05 | 571 | 26 | 6 | GO:0048285 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | 6.32e-05 | 846 | 26 | 7 | GO:0120035 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | 6.71e-05 | 350 | 26 | 5 | GO:0051321 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | 6.71e-05 | 854 | 26 | 7 | GO:1903047 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 7.08e-05 | 354 | 26 | 5 | GO:0050769 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | 7.17e-05 | 863 | 26 | 7 | GO:0031344 | |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | 7.27e-05 | 356 | 26 | 5 | GO:0098813 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 9.27e-05 | 192 | 26 | 4 | GO:0050770 | |
| GeneOntologyBiologicalProcess | organelle disassembly | 1.17e-04 | 204 | 26 | 4 | GO:1903008 | |
| GeneOntologyBiologicalProcess | positive regulation of protein modification process | 1.20e-04 | 937 | 26 | 7 | GO:0031401 | |
| GeneOntologyBiologicalProcess | regulation of autophagy | 1.26e-04 | 400 | 26 | 5 | GO:0010506 | |
| GeneOntologyBiologicalProcess | sexual reproduction | 1.46e-04 | 1312 | 26 | 8 | GO:0019953 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 1.54e-04 | 418 | 26 | 5 | GO:0051962 | |
| GeneOntologyBiologicalProcess | protein homooligomerization | 1.68e-04 | 224 | 26 | 4 | GO:0051260 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | 1.71e-04 | 1342 | 26 | 8 | GO:0033043 | |
| GeneOntologyBiologicalProcess | chromosome organization | 1.72e-04 | 686 | 26 | 6 | GO:0051276 | |
| GeneOntologyBiologicalProcess | regulation of protein binding | 1.80e-04 | 228 | 26 | 4 | GO:0043393 | |
| GeneOntologyBiologicalProcess | organelle localization | 1.97e-04 | 703 | 26 | 6 | GO:0051640 | |
| GeneOntologyBiologicalProcess | chromosome segregation | 2.53e-04 | 465 | 26 | 5 | GO:0007059 | |
| GeneOntologyBiologicalProcess | microtubule-based process | 2.55e-04 | 1058 | 26 | 7 | GO:0007017 | |
| GeneOntologyBiologicalProcess | macromolecule glycosylation | 2.63e-04 | 252 | 26 | 4 | GO:0043413 | |
| GeneOntologyBiologicalProcess | protein glycosylation | 2.63e-04 | 252 | 26 | 4 | GO:0006486 | |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | 2.80e-04 | 475 | 26 | 5 | GO:0140694 | |
| GeneOntologyBiologicalProcess | regulation of stress fiber assembly | 3.24e-04 | 107 | 26 | 3 | GO:0051492 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 3.35e-04 | 494 | 26 | 5 | GO:0031346 | |
| GeneOntologyBiologicalProcess | glycosylation | 3.42e-04 | 270 | 26 | 4 | GO:0070085 | |
| GeneOntologyBiologicalProcess | regulation of protein modification process | 3.47e-04 | 1488 | 26 | 8 | GO:0031399 | |
| GeneOntologyBiologicalProcess | regulatory ncRNA-mediated heterochromatin formation | 3.80e-04 | 23 | 26 | 2 | GO:0031048 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | 4.04e-04 | 1141 | 26 | 7 | GO:0045597 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 4.05e-04 | 515 | 26 | 5 | GO:0050767 | |
| GeneOntologyBiologicalProcess | regulation of actomyosin structure organization | 4.75e-04 | 122 | 26 | 3 | GO:0110020 | |
| GeneOntologyBiologicalProcess | protein complex oligomerization | 4.84e-04 | 296 | 26 | 4 | GO:0051259 | |
| GeneOntologyBiologicalProcess | regulation of actin filament bundle assembly | 4.87e-04 | 123 | 26 | 3 | GO:0032231 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | 5.19e-04 | 1189 | 26 | 7 | GO:0044087 | |
| GeneOntologyBiologicalProcess | contractile actin filament bundle assembly | 5.34e-04 | 127 | 26 | 3 | GO:0030038 | |
| GeneOntologyBiologicalProcess | stress fiber assembly | 5.34e-04 | 127 | 26 | 3 | GO:0043149 | |
| GeneOntologyBiologicalProcess | regulation of urine volume | 6.50e-04 | 30 | 26 | 2 | GO:0035809 | |
| GeneOntologyBiologicalProcess | protein polymerization | 7.62e-04 | 334 | 26 | 4 | GO:0051258 | |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | 8.05e-04 | 339 | 26 | 4 | GO:0048193 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 8.87e-04 | 612 | 26 | 5 | GO:0010975 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 9.00e-04 | 614 | 26 | 5 | GO:0010720 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | 9.20e-04 | 617 | 26 | 5 | GO:0022411 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 9.75e-04 | 625 | 26 | 5 | GO:0051960 | |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | 9.76e-04 | 357 | 26 | 4 | GO:0009101 | |
| GeneOntologyBiologicalProcess | process utilizing autophagic mechanism | 1.16e-03 | 650 | 26 | 5 | GO:0061919 | |
| GeneOntologyBiologicalProcess | autophagy | 1.16e-03 | 650 | 26 | 5 | GO:0006914 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | 1.18e-03 | 1366 | 26 | 7 | GO:0051130 | |
| GeneOntologyBiologicalProcess | regulation of binding | 1.43e-03 | 396 | 26 | 4 | GO:0051098 | |
| GeneOntologyBiologicalProcess | cell division | 1.58e-03 | 697 | 26 | 5 | GO:0051301 | |
| GeneOntologyBiologicalProcess | positive regulation of protein metabolic process | 1.73e-03 | 1458 | 26 | 7 | GO:0051247 | |
| GeneOntologyCellularComponent | cis-Golgi network | 4.92e-08 | 85 | 25 | 5 | GO:0005801 | |
| GeneOntologyCellularComponent | Golgi cis cisterna | 6.36e-08 | 33 | 25 | 4 | GO:0000137 | |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 4.51e-06 | 94 | 25 | 4 | GO:0032580 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 8.43e-06 | 110 | 25 | 4 | GO:0030134 | |
| GeneOntologyCellularComponent | Golgi cisterna | 1.89e-05 | 135 | 25 | 4 | GO:0031985 | |
| GeneOntologyCellularComponent | Golgi stack | 4.78e-05 | 171 | 25 | 4 | GO:0005795 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | 8.23e-05 | 934 | 25 | 7 | GO:0048471 | |
| GeneOntologyCellularComponent | mitotic spindle | 8.96e-05 | 201 | 25 | 4 | GO:0072686 | |
| GeneOntologyCellularComponent | spindle pole | 9.67e-05 | 205 | 25 | 4 | GO:0000922 | |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | 1.56e-04 | 443 | 25 | 5 | GO:0098791 | |
| GeneOntologyCellularComponent | spindle | 2.08e-04 | 471 | 25 | 5 | GO:0005819 | |
| GeneOntologyCellularComponent | supramolecular fiber | 3.49e-04 | 1179 | 25 | 7 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 3.64e-04 | 1187 | 25 | 7 | GO:0099081 | |
| GeneOntologyCellularComponent | microtubule | 3.68e-04 | 533 | 25 | 5 | GO:0005874 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 5.45e-04 | 899 | 25 | 6 | GO:0099513 | |
| GeneOntologyCellularComponent | coated vesicle | 8.22e-04 | 360 | 25 | 4 | GO:0030135 | |
| MousePheno | increased alveolar macrophage number | 6.61e-09 | 14 | 24 | 4 | MP:0014228 | |
| MousePheno | abnormal alveolar macrophage number | 9.01e-09 | 15 | 24 | 4 | MP:0014227 | |
| MousePheno | abnormal surfactant physiology | 4.13e-08 | 58 | 24 | 5 | MP:0004782 | |
| MousePheno | abnormal Golgi vesicle transport | 4.79e-08 | 22 | 24 | 4 | MP:0030949 | |
| MousePheno | abnormal proacrosomal vesicle fusion | 6.94e-08 | 24 | 24 | 4 | MP:0031355 | |
| MousePheno | abnormal alveolar macrophage morphology | 1.14e-07 | 27 | 24 | 4 | MP:0008245 | |
| MousePheno | absent sperm mitochondrial sheath | 1.33e-07 | 28 | 24 | 4 | MP:0009833 | |
| MousePheno | absent acrosome | 2.33e-07 | 32 | 24 | 4 | MP:0008839 | |
| MousePheno | abnormal Golgi apparatus morphology | 2.64e-07 | 33 | 24 | 4 | MP:0011743 | |
| MousePheno | abnormal actin cytoskeleton morphology | 2.99e-07 | 34 | 24 | 4 | MP:0020849 | |
| MousePheno | abnormal microtubule cytoskeleton morphology | 1.04e-06 | 46 | 24 | 4 | MP:0020850 | |
| MousePheno | pulmonary fibrosis | 1.58e-06 | 51 | 24 | 4 | MP:0006050 | |
| MousePheno | immotile sperm | 2.86e-06 | 59 | 24 | 4 | MP:0020869 | |
| MousePheno | abnormal type II pneumocyte morphology | 4.76e-06 | 67 | 24 | 4 | MP:0002275 | |
| MousePheno | decreased Purkinje cell number | 4.76e-06 | 67 | 24 | 4 | MP:0000880 | |
| MousePheno | abnormal Purkinje cell number | 5.36e-06 | 69 | 24 | 4 | MP:0000878 | |
| MousePheno | abnormal sperm nucleus morphology | 7.10e-06 | 74 | 24 | 4 | MP:0009232 | |
| MousePheno | globozoospermia | 7.10e-06 | 74 | 24 | 4 | MP:0002686 | |
| MousePheno | abnormal cell cytoskeleton morphology | 7.49e-06 | 75 | 24 | 4 | MP:0020378 | |
| MousePheno | abnormal pulmonary alveolus epithelial cell morphology | 8.32e-06 | 77 | 24 | 4 | MP:0002273 | |
| MousePheno | liver fibrosis | 8.32e-06 | 77 | 24 | 4 | MP:0003333 | |
| MousePheno | abnormal pulmonary alveolus epithelium morphology | 9.69e-06 | 80 | 24 | 4 | MP:0010898 | |
| MousePheno | decreased body length | 1.18e-05 | 484 | 24 | 7 | MP:0001258 | |
| MousePheno | abnormal pulmonary alveolar parenchyma morphology | 1.55e-05 | 90 | 24 | 4 | MP:0010901 | |
| MousePheno | abnormal acrosome assembly | 1.69e-05 | 92 | 24 | 4 | MP:0031354 | |
| MousePheno | abnormal sperm mitochondrial sheath morphology | 1.92e-05 | 95 | 24 | 4 | MP:0009832 | |
| MousePheno | decreased sperm progressive motility | 2.35e-05 | 100 | 24 | 4 | MP:0020451 | |
| MousePheno | abnormal sperm progressive motility | 2.44e-05 | 101 | 24 | 4 | MP:0020450 | |
| MousePheno | abnormal body length | 2.71e-05 | 550 | 24 | 7 | MP:0001256 | |
| MousePheno | abnormal spermatid morphology | 2.88e-05 | 217 | 24 | 5 | MP:0006380 | |
| MousePheno | abnormal lung epithelium morphology | 4.50e-05 | 118 | 24 | 4 | MP:0006382 | |
| MousePheno | abnormal pulmonary alveolus morphology | 6.21e-05 | 255 | 24 | 5 | MP:0002270 | |
| MousePheno | abnormal neuron number | 9.51e-05 | 456 | 24 | 6 | MP:0008946 | |
| MousePheno | abnormal sperm midpiece morphology | 9.78e-05 | 144 | 24 | 4 | MP:0009831 | |
| MousePheno | abnormal pulmonary acinus morphology | 1.03e-04 | 284 | 24 | 5 | MP:0010911 | |
| MousePheno | abnormal sex determination | 1.17e-04 | 945 | 24 | 8 | MP:0002210 | |
| MousePheno | abnormal pulmonary alveolar system morphology | 1.26e-04 | 296 | 24 | 5 | MP:0010899 | |
| MousePheno | abnormal vesicle-mediated transport | 1.33e-04 | 156 | 24 | 4 | MP:0008546 | |
| MousePheno | abnormal acrosome morphology | 1.43e-04 | 159 | 24 | 4 | MP:0008898 | |
| MousePheno | abnormal hepatocyte morphology | 1.69e-04 | 166 | 24 | 4 | MP:0000607 | |
| MousePheno | abnormal gametogenesis | 2.78e-04 | 1070 | 24 | 8 | MP:0001929 | |
| MousePheno | small testis | 3.42e-04 | 823 | 24 | 7 | MP:0001147 | |
| MousePheno | decreased testis weight | 3.55e-04 | 370 | 24 | 5 | MP:0004852 | |
| MousePheno | abnormal Purkinje cell morphology | 3.72e-04 | 204 | 24 | 4 | MP:0000877 | |
| MousePheno | slow postnatal weight gain | 3.79e-04 | 205 | 24 | 4 | MP:0008489 | |
| MousePheno | decreased neuron number | 3.82e-04 | 376 | 24 | 5 | MP:0008948 | |
| MousePheno | abnormal testis weight | 4.57e-04 | 391 | 24 | 5 | MP:0004850 | |
| MousePheno | abnormal cerebellar Purkinje cell layer | 4.95e-04 | 220 | 24 | 4 | MP:0000875 | |
| MousePheno | postnatal growth retardation | 5.17e-04 | 881 | 24 | 7 | MP:0001732 | |
| MousePheno | maternal effect | 5.21e-04 | 93 | 24 | 3 | MP:0003718 | |
| MousePheno | abnormal sperm number | 5.21e-04 | 624 | 24 | 6 | MP:0002673 | |
| MousePheno | small gonad | 5.31e-04 | 885 | 24 | 7 | MP:0001116 | |
| MousePheno | abnormal liver lobule morphology | 5.76e-04 | 229 | 24 | 4 | MP:0008987 | |
| MousePheno | abnormal respiratory system physiology | 5.76e-04 | 897 | 24 | 7 | MP:0002133 | |
| MousePheno | abnormal primary sex determination | 5.92e-04 | 901 | 24 | 7 | MP:0002211 | |
| MousePheno | decreased male germ cell number | 5.97e-04 | 640 | 24 | 6 | MP:0004901 | |
| MousePheno | abnormal postnatal growth | 6.16e-04 | 907 | 24 | 7 | MP:0001731 | |
| MousePheno | abnormal respiratory epithelium morphology | 6.35e-04 | 235 | 24 | 4 | MP:0010942 | |
| MousePheno | abnormal pregnancy | 6.35e-04 | 235 | 24 | 4 | MP:0009661 | |
| MousePheno | abnormal testis size | 6.50e-04 | 915 | 24 | 7 | MP:0004849 | |
| MousePheno | abnormal spermiogenesis | 6.55e-04 | 237 | 24 | 4 | MP:0001932 | |
| MousePheno | abnormal liver parenchyma morphology | 7.20e-04 | 243 | 24 | 4 | MP:0008986 | |
| MousePheno | abnormal maternal nurturing | 7.43e-04 | 105 | 24 | 3 | MP:0001386 | |
| MousePheno | decreased germ cell number | 8.67e-04 | 687 | 24 | 6 | MP:0002209 | |
| MousePheno | abnormal sperm head morphology | 9.40e-04 | 261 | 24 | 4 | MP:0009230 | |
| MousePheno | abnormal cerebellar layer morphology | 9.67e-04 | 263 | 24 | 4 | MP:0009956 | |
| MousePheno | abnormal maternal behavior | 9.68e-04 | 115 | 24 | 3 | MP:0008779 | |
| MousePheno | ataxia | 1.01e-03 | 266 | 24 | 4 | MP:0001393 | |
| MousePheno | abnormal macrophage cell number | 1.19e-03 | 278 | 24 | 4 | MP:0020202 | |
| MousePheno | abnormal nursing | 1.19e-03 | 30 | 24 | 2 | MP:0001382 | |
| MousePheno | abnormal phagocyte morphology | 1.34e-03 | 1033 | 24 | 7 | MP:0008251 | |
| MousePheno | abnormal sperm flagellum morphology | 1.48e-03 | 295 | 24 | 4 | MP:0008892 | |
| MousePheno | abnormal cerebellar cortex morphology | 1.57e-03 | 300 | 24 | 4 | MP:0004097 | |
| MousePheno | abnormal gametes | 1.73e-03 | 785 | 24 | 6 | MP:0001124 | |
| MousePheno | abnormal testis morphology | 1.74e-03 | 1081 | 24 | 7 | MP:0001146 | |
| MousePheno | abnormal intracellular organelle morphology | 2.05e-03 | 546 | 24 | 5 | MP:0014239 | |
| MousePheno | abnormal parental behavior | 2.50e-03 | 160 | 24 | 3 | MP:0002068 | |
| MousePheno | abnormal male germ cell morphology | 2.74e-03 | 859 | 24 | 6 | MP:0006362 | |
| MousePheno | infertility | 2.99e-03 | 1188 | 24 | 7 | MP:0001924 | |
| MousePheno | asthenozoospermia | 3.12e-03 | 362 | 24 | 4 | MP:0002675 | |
| MousePheno | abnormal cell motility | 3.18e-03 | 885 | 24 | 6 | MP:0020846 | |
| MousePheno | abnormal motile cilium morphology | 3.37e-03 | 370 | 24 | 4 | MP:0013206 | |
| MousePheno | abnormal spermatogenesis | 3.65e-03 | 910 | 24 | 6 | MP:0001156 | |
| MousePheno | hydrops fetalis | 3.69e-03 | 53 | 24 | 2 | MP:0002192 | |
| MousePheno | oligozoospermia | 3.85e-03 | 384 | 24 | 4 | MP:0002687 | |
| MousePheno | increased grip strength | 3.96e-03 | 387 | 24 | 4 | MP:0010052 | |
| MousePheno | abnormal cerebellum morphology | 4.04e-03 | 389 | 24 | 4 | MP:0000849 | |
| MousePheno | male infertility | 4.38e-03 | 944 | 24 | 6 | MP:0001925 | |
| MousePheno | abnormal germ cell morphology | 4.43e-03 | 946 | 24 | 6 | MP:0002208 | |
| MousePheno | abnormal sperm motility | 4.50e-03 | 401 | 24 | 4 | MP:0002674 | |
| MousePheno | abnormal foam cell morphology | 4.61e-03 | 954 | 24 | 6 | MP:0009840 | |
| MousePheno | abnormal male reproductive gland morphology | 4.76e-03 | 1290 | 24 | 7 | MP:0013325 | |
| MousePheno | teratozoospermia | 4.78e-03 | 408 | 24 | 4 | MP:0005578 | |
| MousePheno | abnormal myeloid leukocyte morphology | 4.80e-03 | 1292 | 24 | 7 | MP:0008250 | |
| Domain | GOLGA2L5 | 8.91e-09 | 18 | 26 | 4 | PF15070 | |
| Domain | Golgin_A | 8.91e-09 | 18 | 26 | 4 | IPR024858 | |
| Domain | CH | 3.67e-03 | 65 | 26 | 2 | SM00033 | |
| Domain | CH | 4.25e-03 | 70 | 26 | 2 | PF00307 | |
| Domain | - | 4.37e-03 | 71 | 26 | 2 | 1.10.418.10 | |
| Domain | CH | 4.61e-03 | 73 | 26 | 2 | PS50021 | |
| Domain | DEAD | 4.61e-03 | 73 | 26 | 2 | PF00270 | |
| Domain | DEAD/DEAH_box_helicase_dom | 4.61e-03 | 73 | 26 | 2 | IPR011545 | |
| Domain | CH-domain | 4.86e-03 | 75 | 26 | 2 | IPR001715 | |
| Domain | PH | 6.58e-03 | 278 | 26 | 3 | SM00233 | |
| Domain | PH_DOMAIN | 6.65e-03 | 279 | 26 | 3 | PS50003 | |
| Domain | PH_domain | 6.72e-03 | 280 | 26 | 3 | IPR001849 | |
| Domain | Helicase_C | 9.66e-03 | 107 | 26 | 2 | PF00271 | |
| Domain | HELICc | 9.66e-03 | 107 | 26 | 2 | SM00490 | |
| Domain | Helicase_C | 9.84e-03 | 108 | 26 | 2 | IPR001650 | |
| Domain | HELICASE_CTER | 1.00e-02 | 109 | 26 | 2 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.00e-02 | 109 | 26 | 2 | PS51192 | |
| Domain | DEXDc | 1.00e-02 | 109 | 26 | 2 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.02e-02 | 110 | 26 | 2 | IPR014001 | |
| Pathway | REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION | 3.86e-08 | 23 | 22 | 4 | MM14620 | |
| Pathway | REACTOME_RHOD_GTPASE_CYCLE | 2.66e-06 | 64 | 22 | 4 | MM15601 | |
| Pathway | REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT | 7.54e-06 | 83 | 22 | 4 | MM14819 | |
| Pathway | REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT | 2.30e-05 | 110 | 22 | 4 | MM15350 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 2.65e-05 | 114 | 22 | 4 | MM15361 | |
| Pathway | REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT | 1.20e-04 | 168 | 22 | 4 | MM14785 | |
| Pathway | REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION | 2.45e-04 | 202 | 22 | 4 | MM15650 | |
| Pathway | REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION | 9.95e-04 | 293 | 22 | 4 | MM15120 | |
| Pubmed | Mechanism of primitive duct formation in the pancreas and submandibular glands: a role for SDF-1. | 3.84e-12 | 21 | 27 | 5 | 20003423 | |
| Pubmed | 4.97e-12 | 22 | 27 | 5 | 34897463 | ||
| Pubmed | 1.00e-11 | 25 | 27 | 5 | 29587143 | ||
| Pubmed | Dynein activating adaptor BICD2 controls radial migration of upper-layer cortical neurons in vivo. | 1.24e-11 | 26 | 27 | 5 | 31655624 | |
| Pubmed | Dual function of Yap in the regulation of lens progenitor cells and cellular polarity. | 1.24e-11 | 26 | 27 | 5 | 24384391 | |
| Pubmed | Mouse oocytes develop in cysts with the help of nurse cells. | 1.24e-11 | 26 | 27 | 5 | 35623357 | |
| Pubmed | PTEN dephosphorylates Abi1 to promote epithelial morphogenesis. | 1.24e-11 | 26 | 27 | 5 | 32673396 | |
| Pubmed | Pre-synaptic localization of the γ-secretase-inhibiting protein p24α2 in the mammalian brain. | 1.52e-11 | 27 | 27 | 5 | 25438880 | |
| Pubmed | Neuronal expression of ILEI/FAM3C and its reduction in Alzheimer's disease. | 1.52e-11 | 27 | 27 | 5 | 27256505 | |
| Pubmed | Failure of epithelial tube maintenance causes hydrocephalus and renal cysts in Dlg5-/- mice. | 3.19e-11 | 31 | 27 | 5 | 17765678 | |
| Pubmed | Palmitoylation regulates epidermal homeostasis and hair follicle differentiation. | 5.22e-11 | 34 | 27 | 5 | 19956733 | |
| Pubmed | 1.40e-10 | 41 | 27 | 5 | 26685160 | ||
| Pubmed | GM130 regulates pulmonary surfactant protein secretion in alveolar type II cells. | 2.05e-10 | 13 | 27 | 4 | 33740186 | |
| Pubmed | Loss of GM130 does not impair oocyte meiosis and embryo development in mice. | 2.05e-10 | 13 | 27 | 4 | 32873390 | |
| Pubmed | 2.05e-10 | 13 | 27 | 4 | 21552007 | ||
| Pubmed | GOLGA2 loss causes fibrosis with autophagy in the mouse lung and liver. | 2.05e-10 | 13 | 27 | 4 | 29128360 | |
| Pubmed | Globozoospermia and lack of acrosome formation in GM130-deficient mice. | 2.05e-10 | 13 | 27 | 4 | 28055014 | |
| Pubmed | Loss of the golgin GM130 causes Golgi disruption, Purkinje neuron loss, and ataxia in mice. | 2.05e-10 | 13 | 27 | 4 | 28028212 | |
| Pubmed | 2.87e-10 | 14 | 27 | 4 | 30630895 | ||
| Pubmed | Golgb1 regulates protein glycosylation and is crucial for mammalian palate development. | 2.87e-10 | 14 | 27 | 4 | 27226319 | |
| Pubmed | 2.87e-10 | 14 | 27 | 4 | 37831422 | ||
| Pubmed | Oligoasthenoteratospermia and sperm tail bending in PPP4C-deficient mice. | 2.87e-10 | 14 | 27 | 4 | 33543287 | |
| Pubmed | The a3 isoform of V-ATPase regulates insulin secretion from pancreatic beta-cells. | 3.91e-10 | 15 | 27 | 4 | 17046993 | |
| Pubmed | GM130 Regulates Golgi-Derived Spindle Assembly by Activating TPX2 and Capturing Microtubules. | 3.91e-10 | 15 | 27 | 4 | 26165940 | |
| Pubmed | Mouse oocytes within germ cell cysts and primordial follicles contain a Balbiani body. | 3.91e-10 | 15 | 27 | 4 | 17189423 | |
| Pubmed | Calumin, a novel Ca2+-binding transmembrane protein on the endoplasmic reticulum. | 3.91e-10 | 15 | 27 | 4 | 17204322 | |
| Pubmed | 3.91e-10 | 15 | 27 | 4 | 26083584 | ||
| Pubmed | 3.91e-10 | 15 | 27 | 4 | 16413118 | ||
| Pubmed | 3.91e-10 | 15 | 27 | 4 | 37635409 | ||
| Pubmed | Golgi disruption and early embryonic lethality in mice lacking USO1. | 3.91e-10 | 15 | 27 | 4 | 23185636 | |
| Pubmed | Golga5 is dispensable for mouse embryonic development and postnatal survival. | 3.91e-10 | 15 | 27 | 4 | 28509431 | |
| Pubmed | 5.21e-10 | 16 | 27 | 4 | 16399995 | ||
| Pubmed | 5.21e-10 | 16 | 27 | 4 | 16336229 | ||
| Pubmed | 5.21e-10 | 16 | 27 | 4 | 18166528 | ||
| Pubmed | 5.21e-10 | 16 | 27 | 4 | 11784862 | ||
| Pubmed | p125/Sec23-interacting protein (Sec23ip) is required for spermiogenesis. | 5.21e-10 | 16 | 27 | 4 | 21640725 | |
| Pubmed | Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. | 6.81e-10 | 17 | 27 | 4 | 14718562 | |
| Pubmed | 6.81e-10 | 17 | 27 | 4 | 27655914 | ||
| Pubmed | 6.81e-10 | 17 | 27 | 4 | 14728599 | ||
| Pubmed | 6.81e-10 | 17 | 27 | 4 | 28717168 | ||
| Pubmed | 6.81e-10 | 17 | 27 | 4 | 20004763 | ||
| Pubmed | 8.75e-10 | 18 | 27 | 4 | 21147753 | ||
| Pubmed | 8.75e-10 | 18 | 27 | 4 | 15800058 | ||
| Pubmed | 8.75e-10 | 18 | 27 | 4 | 24227724 | ||
| Pubmed | Altered GLUT4 trafficking in adipocytes in the absence of the GTPase Arfrp1. | 8.75e-10 | 18 | 27 | 4 | 20230794 | |
| Pubmed | 8.75e-10 | 18 | 27 | 4 | 22718342 | ||
| Pubmed | Protein kinase LKB1 regulates polarized dendrite formation of adult hippocampal newborn neurons. | 8.75e-10 | 18 | 27 | 4 | 24367100 | |
| Pubmed | 8.75e-10 | 18 | 27 | 4 | 20943658 | ||
| Pubmed | 8.75e-10 | 18 | 27 | 4 | 25208654 | ||
| Pubmed | 1.11e-09 | 19 | 27 | 4 | 23444373 | ||
| Pubmed | 1.11e-09 | 19 | 27 | 4 | 12646573 | ||
| Pubmed | Stage-dependent function of Wnt5a during male external genitalia development. | 1.11e-09 | 19 | 27 | 4 | 34255394 | |
| Pubmed | 1.11e-09 | 19 | 27 | 4 | 15452145 | ||
| Pubmed | Scrg1, a novel protein of the CNS is targeted to the large dense-core vesicles in neuronal cells. | 1.11e-09 | 19 | 27 | 4 | 14622145 | |
| Pubmed | CLASP2 safeguards hematopoietic stem cell properties during mouse and fish development. | 1.11e-09 | 19 | 27 | 4 | 35705037 | |
| Pubmed | Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo. | 1.11e-09 | 19 | 27 | 4 | 17664336 | |
| Pubmed | Deletion of IFT20 exclusively in the RPE ablates primary cilia and leads to retinal degeneration. | 1.11e-09 | 19 | 27 | 4 | 38048369 | |
| Pubmed | 1.11e-09 | 19 | 27 | 4 | 17724343 | ||
| Pubmed | 1.11e-09 | 19 | 27 | 4 | 22841714 | ||
| Pubmed | Regulation of amino acid transporter ATA2 by ubiquitin ligase Nedd4-2. | 1.11e-09 | 19 | 27 | 4 | 17003038 | |
| Pubmed | Cell influx and contractile actomyosin force drive mammary bud growth and invagination. | 1.11e-09 | 19 | 27 | 4 | 34042944 | |
| Pubmed | The COPI vesicle complex binds and moves with survival motor neuron within axons. | 1.38e-09 | 20 | 27 | 4 | 21300694 | |
| Pubmed | Intraflagellar transport molecules in ciliary and nonciliary cells of the retina. | 1.38e-09 | 20 | 27 | 4 | 20368623 | |
| Pubmed | 1.38e-09 | 20 | 27 | 4 | 23918928 | ||
| Pubmed | Maximizing the ovarian reserve in mice by evading LINE-1 genotoxicity. | 1.38e-09 | 20 | 27 | 4 | 31949138 | |
| Pubmed | Development of the post-natal growth plate requires intraflagellar transport proteins. | 1.38e-09 | 20 | 27 | 4 | 17359961 | |
| Pubmed | The molecular complex of ciliary and golgin protein is crucial for skull development. | 1.38e-09 | 20 | 27 | 4 | 34128978 | |
| Pubmed | 1.38e-09 | 20 | 27 | 4 | 30236446 | ||
| Pubmed | Overlapping Role of SCYL1 and SCYL3 in Maintaining Motor Neuron Viability. | 1.38e-09 | 20 | 27 | 4 | 29437892 | |
| Pubmed | GOLGA6C GOLGA6D DLG4 GOLGA6B GOLGA6A LIMCH1 SBF1 SYNE2 SPICE1 PCNT | 1.39e-09 | 963 | 27 | 10 | 28671696 | |
| Pubmed | 1.41e-09 | 64 | 27 | 5 | 34174788 | ||
| Pubmed | Rap2 function requires palmitoylation and recycling endosome localization. | 1.71e-09 | 21 | 27 | 4 | 19061864 | |
| Pubmed | 1.71e-09 | 21 | 27 | 4 | 15229288 | ||
| Pubmed | Canonical and noncanonical intraflagellar transport regulates craniofacial skeletal development. | 1.71e-09 | 21 | 27 | 4 | 27118846 | |
| Pubmed | Ror2 enhances polarity and directional migration of primordial germ cells. | 1.71e-09 | 21 | 27 | 4 | 22216013 | |
| Pubmed | 1.71e-09 | 21 | 27 | 4 | 23386608 | ||
| Pubmed | 1.71e-09 | 21 | 27 | 4 | 21645620 | ||
| Pubmed | 1.71e-09 | 21 | 27 | 4 | 36292593 | ||
| Pubmed | Control of craniofacial development by the collagen receptor, discoidin domain receptor 2. | 2.09e-09 | 22 | 27 | 4 | 36656123 | |
| Pubmed | 2.52e-09 | 23 | 27 | 4 | 25636444 | ||
| Pubmed | 2.52e-09 | 23 | 27 | 4 | 37848288 | ||
| Pubmed | 2.52e-09 | 23 | 27 | 4 | 18662990 | ||
| Pubmed | Reelin and stk25 have opposing roles in neuronal polarization and dendritic Golgi deployment. | 2.52e-09 | 23 | 27 | 4 | 21111240 | |
| Pubmed | 2.52e-09 | 23 | 27 | 4 | 18001291 | ||
| Pubmed | Pofut1 is required for the proper localization of the Notch receptor during mouse development. | 2.52e-09 | 23 | 27 | 4 | 18547789 | |
| Pubmed | 3.03e-09 | 24 | 27 | 4 | 24161848 | ||
| Pubmed | 3.03e-09 | 24 | 27 | 4 | 38814743 | ||
| Pubmed | The PCP genes Celsr1 and Vangl2 are required for normal lung branching morphogenesis. | 3.03e-09 | 24 | 27 | 4 | 20223754 | |
| Pubmed | 3.03e-09 | 24 | 27 | 4 | 26060116 | ||
| Pubmed | Dual role for CXCL12 signaling in semilunar valve development. | 3.03e-09 | 24 | 27 | 4 | 34433040 | |
| Pubmed | Essential role of cyclin-G-associated kinase (Auxilin-2) in developing and mature mice. | 3.03e-09 | 24 | 27 | 4 | 18434600 | |
| Pubmed | 3.03e-09 | 24 | 27 | 4 | 21187406 | ||
| Pubmed | Stalk cell phenotype depends on integration of Notch and Smad1/5 signaling cascades. | 3.03e-09 | 24 | 27 | 4 | 22364862 | |
| Pubmed | 3.60e-09 | 25 | 27 | 4 | 26582200 | ||
| Pubmed | Nubp1 is required for lung branching morphogenesis and distal progenitor cell survival in mice. | 3.60e-09 | 25 | 27 | 4 | 23028652 | |
| Pubmed | Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer. | 3.60e-09 | 25 | 27 | 4 | 15078902 | |
| Pubmed | 3.60e-09 | 25 | 27 | 4 | 26143639 | ||
| Pubmed | 3.60e-09 | 25 | 27 | 4 | 27471260 | ||
| Pubmed | Gestational stress induces the unfolded protein response, resulting in heart defects. | 3.60e-09 | 25 | 27 | 4 | 27436040 | |
| Pubmed | 3.60e-09 | 25 | 27 | 4 | 24161523 | ||
| Interaction | CLRN3 interactions | 1.54e-09 | 13 | 26 | 4 | int:CLRN3 | |
| Interaction | DBN1 interactions | 7.23e-07 | 417 | 26 | 7 | int:DBN1 | |
| Interaction | TRIM52 interactions | 2.42e-05 | 133 | 26 | 4 | int:TRIM52 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q24 | 7.94e-07 | 122 | 27 | 4 | chr15q24 | |
| Cytoband | 15q24.2 | 1.63e-04 | 32 | 27 | 2 | 15q24.2 | |
| Cytoband | 15q24.1 | 1.85e-04 | 34 | 27 | 2 | 15q24.1 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.23e-02 | 206 | 15 | 2 | 682 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-06 | 167 | 27 | 4 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.44e-06 | 194 | 27 | 4 | 24837a27b0041fe8c348225fa8b09b127d743603 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 6.02e-06 | 199 | 27 | 4 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | LPS-antiTNF-Unknown|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.40e-05 | 129 | 27 | 3 | 739b263296c28554967362060b154f7a95e1341d | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.55e-05 | 130 | 27 | 3 | 615c233c7c2600c1c2bc5cf5b1c501fc474564ef | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.44e-05 | 147 | 27 | 3 | 9566398275cad79223db90ffe640830acf2db864 | |
| ToppCell | COVID-CD4-proli_CD4|COVID / Condition, Cell_class and T cell subcluster | 1.02e-04 | 151 | 27 | 3 | dd40dfc5b1211d31607e16d9b433a5c1796e7edf | |
| ToppCell | BAL-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 1.08e-04 | 154 | 27 | 3 | 0121d08cc527aed9b3e11ff62bb9012916f5c56b | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.28e-04 | 163 | 27 | 3 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 165 | 27 | 3 | 88681101d7cf60b99b8ace5d8c0944323b937306 | |
| ToppCell | Ionocyte-iono-3|World / Class top | 1.35e-04 | 166 | 27 | 3 | 9c4a780f8af46d7552077c7a0ae0ab1b2413e5d4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 167 | 27 | 3 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-04 | 168 | 27 | 3 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 169 | 27 | 3 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 169 | 27 | 3 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-CD4_CTL|ICU-NoSEP / Disease, Lineage and Cell Type | 1.43e-04 | 169 | 27 | 3 | cbda36f32bd78322dcfe303a44413415d08e5ea3 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 170 | 27 | 3 | e20568c8f3f17d94de78229617eb2f7e4c5af2bc | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 170 | 27 | 3 | b1a16600754e0c12f7d39c9221f1b03135833f16 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.48e-04 | 171 | 27 | 3 | b113fbebb89056af0b9c775d2fb6552206a80467 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.53e-04 | 173 | 27 | 3 | a25459b8140b0dbcb73e3b4cc1407b679229f25c | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-B_cells-Cycling_B_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.53e-04 | 173 | 27 | 3 | b7e0193fd4983cb38d1bee441f608f73ee8743b9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 174 | 27 | 3 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like|blood / Manually curated celltypes from each tissue | 1.55e-04 | 174 | 27 | 3 | 51be6f29308c01593978cbee92114151a5916c9c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_endothelial_cell_-_unspecif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 174 | 27 | 3 | 4d8c4a7d8f4972da68cebe0a79eb1a14ec546121 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 174 | 27 | 3 | c26eac176e9b0cba385630fdc60e0314a4e4caac | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-CD4_TEM|Multiple_Sclerosis / Disease, Lineage and Cell Type | 1.55e-04 | 174 | 27 | 3 | d2ea5b55bf03a8013816d073896208f311c3e544 | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like-MAIT|blood / Manually curated celltypes from each tissue | 1.58e-04 | 175 | 27 | 3 | b4e4b66e89f79999768a6192c8404cb2465f920b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-04 | 175 | 27 | 3 | bb058e714d21a0ec8532eaf3c7dd2faf78016bc0 | |
| ToppCell | IIF-Lymphocyte-T_NK-CD4_TEM|IIF / Disease, Lineage and Cell Type | 1.58e-04 | 175 | 27 | 3 | 0e7cde3bd638ab85abe915d40c432123f92af4fc | |
| ToppCell | lung|World / shred on tissue and cell subclass | 1.66e-04 | 178 | 27 | 3 | 7b1e371272328d6b6c3994382d64281ffc737db2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-04 | 179 | 27 | 3 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-04 | 179 | 27 | 3 | 80112c686a8f85ad5e3cda6e3f3d3d51cf688092 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c08-GZMK-FOS_h|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.72e-04 | 180 | 27 | 3 | 05f14cd367021891166825a8aac171227e2bcd97 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.72e-04 | 180 | 27 | 3 | f8a15c13d85c1bbbf86ce49bb6f86c368ddf22df | |
| ToppCell | control-Lymphoid-NKT-proliferating|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.72e-04 | 180 | 27 | 3 | 535535a67b3f3320bad2f98b1bc98a7b0ee77840 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.80e-04 | 183 | 27 | 3 | 317b756378a9efd8ecb754acf7273f83f996e106 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-04 | 184 | 27 | 3 | 6b2449ac65a2322aa0479fba0d89828f243aabbe | |
| ToppCell | 343B-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.83e-04 | 184 | 27 | 3 | e90622b82fa7f16a1faaf7a4724c958f2d83341d | |
| ToppCell | Healthy/Control-CD4+_CTL|Healthy/Control / Disease group and Cell class | 1.83e-04 | 184 | 27 | 3 | 6c6ffa150f81e456f88e9065de90c2dcda417589 | |
| ToppCell | Control-Lymphocyte-T_NK-CD4_TEM|Control / Disease, Lineage and Cell Type | 1.86e-04 | 185 | 27 | 3 | 8d6a089dcb4bfb0e74b6316fb7221688c1835e6e | |
| ToppCell | metastatic_Brain-T/NK_cells-Naive_CD4+_T|T/NK_cells / Location, Cell class and cell subclass | 1.86e-04 | 185 | 27 | 3 | 2eee26c28b130be6163f27bc608384c054238501 | |
| ToppCell | tumor_Lung-T/NK_cells-Cytotoxic_CD8+_T|tumor_Lung / Location, Cell class and cell subclass | 1.92e-04 | 187 | 27 | 3 | 530839fb53bb285b22919fde6aa16ce1399615ef | |
| ToppCell | CV-Severe-3|Severe / Virus stimulation, Condition and Cluster | 1.92e-04 | 187 | 27 | 3 | 68cb43a73945f5e252530da25613f6b3f484b4d5 | |
| ToppCell | Healthy/Control-CD4+_CTL|World / Disease group and Cell class | 1.92e-04 | 187 | 27 | 3 | d54d3214d77a9469e94a16c00a80626fd4953e2b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 187 | 27 | 3 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | (1)_T_CD4_naive|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.95e-04 | 188 | 27 | 3 | b8f67ac2faadd5b848955e43ab5d6cf5e49b3681 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.95e-04 | 188 | 27 | 3 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMK+-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.95e-04 | 188 | 27 | 3 | 2513ca0efa73c09a3406b99e2876982d78b173d7 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-04 | 189 | 27 | 3 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.01e-04 | 190 | 27 | 3 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.01e-04 | 190 | 27 | 3 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | ASK428-Immune-NK_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.01e-04 | 190 | 27 | 3 | d649f7e17c4227787465dfc02037f791ff85378b | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-CD8_TEM|Bac-SEP / Disease, Lineage and Cell Type | 2.04e-04 | 191 | 27 | 3 | 84e3aaed71bd35d73af475d610d1b7e71df9ce3f | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.04e-04 | 191 | 27 | 3 | de25b2a4b5daadb05a54b1262557398da6314e7f | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-04 | 191 | 27 | 3 | adb2e3efcad02889d8229325080da5e7830fd3ae | |
| ToppCell | ASK454-Immune-T_cell|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.11e-04 | 193 | 27 | 3 | 27c38a364bcdb4c0967155f18aa81d37e17c920b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.11e-04 | 193 | 27 | 3 | c3cffafc1d40c3d7cf81034d5c51f1c78f5eb0a9 | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.11e-04 | 193 | 27 | 3 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | ASK454-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.11e-04 | 193 | 27 | 3 | 11e1db416dc9a0b99ddb72d6021fba6e25405b5c | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-CD8_TEM|ICU-NoSEP / Disease, Lineage and Cell Type | 2.11e-04 | 193 | 27 | 3 | 848d47d3b1035f0fb36911d71d48976ee9d013fc | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.14e-04 | 194 | 27 | 3 | f15e81ff12525523c62d13105cf264ea72205e2e | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD8_TEM|ICU-SEP / Disease, Lineage and Cell Type | 2.14e-04 | 194 | 27 | 3 | 5dbf0e3d8ccc389220f1fceaa2e99c85a1c4d818 | |
| ToppCell | 3'_v3-blood-Lymphocytic_NK-Cycling_NK|blood / Manually curated celltypes from each tissue | 2.14e-04 | 194 | 27 | 3 | bf9734abaad603ade2a6a6940918aaf1e1c4e2cd | |
| ToppCell | BLOOD--(1)_MAIT-like_CD8_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.14e-04 | 194 | 27 | 3 | 0064bcd9ac2fecec81f8d4e7d9f86f0089872fe7 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.14e-04 | 194 | 27 | 3 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD4_CTL|ICU-SEP / Disease, Lineage and Cell Type | 2.14e-04 | 194 | 27 | 3 | ca7f5ae54313b3728d6e6e4f801dc420d5406930 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.14e-04 | 194 | 27 | 3 | 8f4b63b0b9a40765205e4ca6bd94a675a83dbe3d | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-MAIT|Liver / Manually curated celltypes from each tissue | 2.17e-04 | 195 | 27 | 3 | 6da0db2a36a34952daab87d74367b491582dedea | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like|Liver / Manually curated celltypes from each tissue | 2.17e-04 | 195 | 27 | 3 | 37853fe760eac27ecb2fe42ebff42deca0153400 | |
| ToppCell | MS-CD4-memory_CD4|MS / Condition, Cell_class and T cell subcluster | 2.17e-04 | 195 | 27 | 3 | 41ef1304800eda995df88c6057e9835ea31e9125 | |
| ToppCell | proximal-3-Hematologic-IGSF21+_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.17e-04 | 195 | 27 | 3 | 8592d0332bc82a91e173680cfd1afc5ee189b289 | |
| ToppCell | proximal-Hematologic-IGSF21+_Dendritic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.17e-04 | 195 | 27 | 3 | c48ff83c48342875f06c6c9e7d5bc6084a992848 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasmablasts|lymph-node_spleen / Manually curated celltypes from each tissue | 2.17e-04 | 195 | 27 | 3 | 1390728b9a514db534e8bc6dcf72cf51a1065780 | |
| ToppCell | mild_COVID-19-CD4+_CTL|World / disease group, cell group and cell class (v2) | 2.17e-04 | 195 | 27 | 3 | 980909246c30471c9f2f97c3b20b6d6d20fe574e | |
| ToppCell | proximal-Hematologic-IGSF21+_Dendritic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.17e-04 | 195 | 27 | 3 | ae9d61011e95f7840cbb154738c79745fd29943e | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.17e-04 | 195 | 27 | 3 | b072fdc2131173f562e55dd78226eaf2c57d3690 | |
| ToppCell | Healthy-CD4+_CTL|World / disease group, cell group and cell class | 2.20e-04 | 196 | 27 | 3 | 6a623eeb2ba8d4e16543820bcbba41eecbd00ed2 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD8-Trm/em_CD8|Lung / Manually curated celltypes from each tissue | 2.20e-04 | 196 | 27 | 3 | cbb63b9ea85b2060e90dd551aa4e697b3f1494fc | |
| ToppCell | COVID-CD4-memory_CD4|COVID / Condition, Cell_class and T cell subcluster | 2.20e-04 | 196 | 27 | 3 | a4fb3abf3c38928da9e8281dee8a304e8fd55eab | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.20e-04 | 196 | 27 | 3 | 0f3c7fd450aaa1f866b8558692534c0ea2a34e75 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-Gamma_Delta_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.20e-04 | 196 | 27 | 3 | 6eabbac1625f715531bae562a28da27664572600 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.20e-04 | 196 | 27 | 3 | 4e1f8828413896ab8a4ec92a89d6789e8e37e05a | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 2.20e-04 | 196 | 27 | 3 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Healthy-CD4+_CTL|Healthy / disease group, cell group and cell class | 2.20e-04 | 196 | 27 | 3 | 9da0ea4ad84d6e20e4349d3d1a8cc4d61d08c84f | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.20e-04 | 196 | 27 | 3 | c647ce58de4c5bb4ceb1123690e637eae4ae1b82 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 2.20e-04 | 196 | 27 | 3 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | severe-CD8+_Tem|severe / disease stage, cell group and cell class | 2.20e-04 | 196 | 27 | 3 | 9456a5879948e25bc483a7233c274da841ef2c68 | |
| ToppCell | COVID-19-Lymphoid-CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 2.20e-04 | 196 | 27 | 3 | 28515d8e2f02366fa0ac1bea251a7a3f659c98c7 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.20e-04 | 196 | 27 | 3 | a2db88fad9bbc55685f8e681d120ef38715ca3c4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.20e-04 | 196 | 27 | 3 | c100967851f037b3522130a9e2a4175ad593ecbc | |
| ToppCell | Healthy_donor-CD4+_CTL|Healthy_donor / disease group, cell group and cell class (v2) | 2.24e-04 | 197 | 27 | 3 | 48592619b4d6cd1898ed1c2d1d447193efad9efa | |
| ToppCell | severe-Lymphocytic-NK_cells|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.24e-04 | 197 | 27 | 3 | 8bf88b10d49ac499e7d0ba5b7023909e1fd7b29a | |
| ToppCell | mLN-B_cell-B_cell_cycling|mLN / Region, Cell class and subclass | 2.24e-04 | 197 | 27 | 3 | 806dddcca85c82bd642008d930c8db16b613d88e | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD8|Lung / Manually curated celltypes from each tissue | 2.24e-04 | 197 | 27 | 3 | b2f5b35e931c1342e541ecf05933350c41612415 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.24e-04 | 197 | 27 | 3 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | mLN-(2)_B_cell-(24)_B_cell_cycling|mLN / shred on region, Cell_type, and subtype | 2.24e-04 | 197 | 27 | 3 | 70fff2d6723f259e18e7a21d22dc46d71f0759ce | |
| ToppCell | control-Lymphocytic-CD8_T_cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.24e-04 | 197 | 27 | 3 | c1c47db5e8d1b248bc192556275edd1ce168a953 | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.24e-04 | 197 | 27 | 3 | b5b333e98753946793ceb45e2d85c25ef53568b4 | |
| ToppCell | CV-Moderate|CV / Virus stimulation, Condition and Cluster | 2.24e-04 | 197 | 27 | 3 | 8747a57ded96175a8365f066101ce2af80c8081d | |
| ToppCell | Severe-Lymphoid-NK-NK|Severe / Condition, Lineage, Cell class and cell subclass | 2.24e-04 | 197 | 27 | 3 | d5b94f9f73e9d050245841b19b046242a32c6258 | |
| Drug | Glibenclamide [10238-21-8]; Down 200; 8uM; MCF7; HT_HG-U133A | 1.30e-06 | 195 | 23 | 5 | 3163_DN | |
| Drug | THIP Hydrochloride; Down 200; 22.6uM; MCF7; HT_HG-U133A | 1.44e-06 | 199 | 23 | 5 | 6511_DN | |
| Drug | carbamazepine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.60e-05 | 189 | 23 | 4 | 835_UP | |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 3.75e-05 | 191 | 23 | 4 | 5456_DN | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Down 200; 12uM; PC3; HT_HG-U133A | 3.83e-05 | 192 | 23 | 4 | 7155_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A | 3.83e-05 | 192 | 23 | 4 | 1634_UP | |
| Drug | Antazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 4.07e-05 | 195 | 23 | 4 | 3173_DN | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 4.07e-05 | 195 | 23 | 4 | 1521_DN | |
| Drug | Tetrahydroalstonine [6474-90-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 4.07e-05 | 195 | 23 | 4 | 2748_DN | |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 23 | 4 | 4987_DN | |
| Drug | Chlorhexidine [55-56-1]; Up 200; 8uM; MCF7; HT_HG-U133A | 4.23e-05 | 197 | 23 | 4 | 5403_UP | |
| Drug | Doxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 4.23e-05 | 197 | 23 | 4 | 7195_DN | |
| Drug | Bupropion hydrochloride [31677-93-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 4.23e-05 | 197 | 23 | 4 | 3180_DN | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 4.23e-05 | 197 | 23 | 4 | 3846_DN | |
| Drug | Isocarboxazid [59-63-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 4.23e-05 | 197 | 23 | 4 | 7383_DN | |
| Drug | Iopamidol [60166-93-0]; Up 200; 5.2uM; HL60; HT_HG-U133A | 4.32e-05 | 198 | 23 | 4 | 2732_UP | |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 4.32e-05 | 198 | 23 | 4 | 5019_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; MCF7; HT_HG-U133A | 4.40e-05 | 199 | 23 | 4 | 6982_UP | |
| Drug | Thyroxine (L) [51-48-9]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 4.40e-05 | 199 | 23 | 4 | 3249_DN | |
| Drug | D-cycloserine [68-41-7]; Down 200; 39.2uM; PC3; HT_HG-U133A | 4.49e-05 | 200 | 23 | 4 | 7134_DN | |
| Drug | Perimed | 1.16e-04 | 16 | 23 | 2 | CID003081043 | |
| Drug | AC1O0B8G | 1.28e-04 | 262 | 23 | 4 | CID000091605 | |
| Drug | 4,4'-DBP | 1.65e-04 | 19 | 23 | 2 | CID000007034 | |
| Drug | 5-fluorocytidine | 2.89e-04 | 25 | 23 | 2 | CID000016861 | |
| Drug | Arg-pro-pro | 3.37e-04 | 27 | 23 | 2 | CID000152660 | |
| Drug | AC1MIZJD | 3.90e-04 | 29 | 23 | 2 | CID003082805 | |
| Drug | AC1L1CWO | 5.69e-04 | 35 | 23 | 2 | CID000002095 | |
| Drug | Bisacodyl [603-50-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 6.60e-04 | 171 | 23 | 3 | 3297_UP | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 7.42e-04 | 178 | 23 | 3 | 6220_UP | |
| Drug | diisopropylamine | 7.44e-04 | 40 | 23 | 2 | CID000007912 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 7.91e-04 | 182 | 23 | 3 | 6316_UP | |
| Drug | 15d-PGJ2; Up 200; 10uM; MCF7; HT_HG-U133A | 7.91e-04 | 182 | 23 | 3 | 6990_UP | |
| Drug | pioglitazone HCl; Up 200; 10uM; PC3; HT_HG-U133A | 8.29e-04 | 185 | 23 | 3 | 7528_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 8.29e-04 | 185 | 23 | 3 | 5585_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A_EA | 8.82e-04 | 189 | 23 | 3 | 989_UP | |
| Drug | Rolipram [61413-54-5]; Up 200; 14.6uM; HL60; HT_HG-U133A | 8.82e-04 | 189 | 23 | 3 | 3072_UP | |
| Drug | PHA-00846566E [724718-26-7]; Down 200; 10uM; PC3; HT_HG-U133A | 9.09e-04 | 191 | 23 | 3 | 7086_DN | |
| Drug | Nitrofural [59-87-0]; Down 200; 20.2uM; PC3; HT_HG-U133A | 9.09e-04 | 191 | 23 | 3 | 6721_DN | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; PC3; HT_HG-U133A | 9.09e-04 | 191 | 23 | 3 | 2048_DN | |
| Drug | Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; HL60; HT_HG-U133A | 9.09e-04 | 191 | 23 | 3 | 2937_DN | |
| Drug | Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 9.23e-04 | 192 | 23 | 3 | 3460_UP | |
| Drug | Clorgyline hydrochloride [17780-75-5]; Down 200; 13uM; PC3; HT_HG-U133A | 9.23e-04 | 192 | 23 | 3 | 6659_DN | |
| Drug | 5155877; Up 200; 10uM; PC3; HT_HG-U133A | 9.23e-04 | 192 | 23 | 3 | 6544_UP | |
| Drug | Equilin [474-86-2]; Up 200; 15uM; MCF7; HT_HG-U133A | 9.23e-04 | 192 | 23 | 3 | 5620_UP | |
| Drug | Zidovudine, AZT [30516-87-1]; Down 200; 15uM; PC3; HT_HG-U133A | 9.37e-04 | 193 | 23 | 3 | 6733_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; PC3; HG-U133A | 9.37e-04 | 193 | 23 | 3 | 1961_DN | |
| Drug | geldanamycin; Down 200; 1uM; HL60; HT_HG-U133A | 9.37e-04 | 193 | 23 | 3 | 2688_DN | |
| Drug | oxaprozin; Up 200; 300uM; MCF7; HT_HG-U133A_EA | 9.37e-04 | 193 | 23 | 3 | 971_UP | |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 3859_DN | |
| Drug | 5248896; Up 200; 11uM; MCF7; HT_HG-U133A_EA | 9.51e-04 | 194 | 23 | 3 | 955_UP | |
| Drug | Methazolamide [554-57-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 3474_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; MCF7; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 3404_UP | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 6833_DN | |
| Drug | Pyrilamine maleate [59-33-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 3184_DN | |
| Drug | Scopolamine hydrochloride [55-16-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 4219_DN | |
| Drug | Oxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 3168_DN | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 7000_UP | |
| Drug | Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; HL60; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 2405_DN | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 3835_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 4686_UP | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 3909_DN | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 2234_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 6999_UP | |
| Drug | Sulfapyridine [144-83-2]; Down 200; 16uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 6101_DN | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 1660_UP | |
| Drug | Cefoperazone dihydrate; Down 200; 5.8uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 5424_DN | |
| Drug | Streptozotocin [18883-66-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 6098_DN | |
| Drug | Thiamphenicol [15318-45-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 7033_UP | |
| Drug | Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; PC3; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 7394_DN | |
| Drug | Berberine chloride [633-65-8]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 2770_UP | |
| Drug | Scopoletin [92-61-5]; Down 200; 20.8uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 6510_DN | |
| Drug | 3-Acetamidocoumarin [779-30-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 7361_UP | |
| Drug | 17-DMAG; Down 200; 0.1uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 5573_DN | |
| Drug | Rescinnamin [24815-24-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 4386_DN | |
| Drug | Coralyne chloride hydrate [38989-38-7]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 5418_DN | |
| Drug | Sulfasalazine [599-79-1]; Down 200; 10uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 5446_DN | |
| Drug | Sotalol hydrochloride [959-24-0]; Up 200; 13uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 7338_UP | |
| Drug | Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 3567_DN | |
| Drug | Norfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 2090_DN | |
| Drug | S-(+)-ibuprofen [51146-56-6]; Down 200; 19.4uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 6471_DN | |
| Drug | Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 3192_DN | |
| Drug | Methoxy-8-psoralen [298-81-7]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 3302_DN | |
| Drug | Risperidone [106266-06-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 3508_UP | |
| Drug | Sulfaquinoxaline sodium salt [967-80-6]; Up 200; 12.4uM; HL60; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 2528_UP | |
| Drug | Cefmetazole sodium salt [56796-39-5]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 7222_DN | |
| Drug | Fluvoxamine maleate [61718-82-9]; Up 200; 9.2uM; HL60; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 2913_UP | |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 6766_DN | |
| Drug | Iodixanol [92339-11-2]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 3362_DN | |
| Drug | Lovastatin [75330-75-5]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 4978_DN | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 4749_DN | |
| Drug | Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 2217_UP | |
| Drug | Antazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 6775_DN | |
| Drug | Alcuronium chloride [15180-03-7]; Down 200; 5.4uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 4409_DN | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 3277_UP | |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 1516_DN | |
| Drug | Denatonium benzoate [3734-33-6]; Up 200; 9uM; HL60; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 3123_UP | |
| Drug | 100 fM | 9.83e-04 | 46 | 23 | 2 | CID000023998 | |
| Drug | Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 2305_UP | |
| Drug | Tamoxifen citrate [54965-24-1]; Down 200; 7uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 6768_DN | |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 1uM; PC3; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 7390_DN | |
| Disease | Seckel syndrome | 1.21e-04 | 22 | 22 | 2 | C0265202 | |
| Disease | cutaneous melanoma, hair color | 9.77e-04 | 62 | 22 | 2 | EFO_0000389, EFO_0003924 | |
| Disease | Malignant neoplasm of breast | 9.94e-04 | 1074 | 22 | 5 | C0006142 | |
| Disease | Autism Spectrum Disorders | 1.82e-03 | 85 | 22 | 2 | C1510586 | |
| Disease | HIV-1 infection | 2.42e-03 | 98 | 22 | 2 | EFO_0000180 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.66e-03 | 103 | 22 | 2 | EFO_0008595, EFO_0020944 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EWEEWRRRKEKLLKE | 96 | Q96CN4 | |
| RKRDEWLARWKREAE | 201 | Q9Y6K1 | |
| RWRERWCRVKDNKLI | 361 | Q8N556 | |
| RKKWNKWALSRGKRE | 31 | P35318 | |
| EKRLWDQEERLWKKE | 406 | Q9NYA3 | |
| LCVWWTRKRRKERER | 1101 | Q9Y219 | |
| EKRLWDQEERLWKKE | 406 | A6NDN3 | |
| QWRKWQRDKEKLREL | 2906 | O95613 | |
| RWKDTWDRVKAAQRL | 1671 | O95248 | |
| RRAKWRRQEKLKWEM | 221 | O43316 | |
| KKRKPAWTDRILWRL | 261 | Q9BT40 | |
| AKRWLGKLRRKRRWR | 51 | A0A0U1RRI6 | |
| EKRLWDQEERLWKKE | 406 | A6NDK9 | |
| KRRVERREWSRLKAK | 491 | P78352 | |
| EKRLWDQEERLWKKE | 406 | P0CG33 | |
| KLWNRVKWTRDEDDK | 31 | P10243 | |
| DDKWQDDLARWKSRR | 361 | Q9UPQ0 | |
| ERRMKIEETWRLWQK | 6126 | Q8WXH0 | |
| SRLLRKQAWKQKWRK | 371 | O94761 | |
| KREQWKKLRRESWER | 121 | Q9Y6M9 | |
| WELQEKALKRKWRKQ | 66 | Q8N0Z3 | |
| RWRKERIEREQWLRD | 1171 | Q9HAW4 | |
| WAATRWAKKIEARER | 86 | P50914 | |
| DKKWNSCVRRRKWIR | 151 | Q7Z6L1 | |
| TWTKDSKRRDKRWVK | 106 | O60504 | |
| KWDILSRRWKQRKNV | 1431 | O75643 | |
| DQKWRWQLEEERKRR | 871 | Q07283 |